Lilly’s Pill Power Play: Foundayo Grabs a Third of New GLP-1 Starts

‼️ Eli Lilly CEO Dave Ricks said one-third of new GLP-1 pill patients are now starting on the company’s oral drug, Foundayo, as Lilly broke ground on a new Houston manufacturing site to ramp up its production.

Leave a comment